索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]付聪,石静,孔一慧.长链非编码RNA在原发性高血压中的研究进展[J].国际心血管病杂志,2021,06:341-344.
点击复制

长链非编码RNA在原发性高血压中的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2021年06期
页码:
341-344
栏目:
综述
出版日期:
2021-12-01

文章信息/Info

Title:
-
作者:
付聪; 石静; 孔一慧
150001 哈尔滨医科大学附属第一医院心血管内科五病房
Author(s):
-
关键词:
原发性高血压;  长链非编码RNA;  生物学功能
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2021.06.006
文献标识码:
-
摘要:
血管平滑肌细胞、内皮细胞和周细胞的凋亡、增殖表型改变可导致血管壁的增厚和重构,使血管阻力改变,促进高血压发生发展。长链非编码RNA(lncRNA)可作用于mRNA,通过对血管细胞功能和细胞周期的调控参与原发性高血压的发生发展。
Abstract:
-

参考文献/References

[1] Singh M, Singh AK, Pandey P, et al. Molecular genetics of essential hypertension[J]. Clin Exp Hypertens, 2016, 38(3):268-277.
[2] Arif M, Sadayappan S, Becker RC, et al. Epigenetic modification: a regulatory mechanism in essential hypertension[J]. Hypertens Res, 2019, 42(8):1099-1113.
[3] Rotllan N, Wanschel AC, Fernández-Hernando A, et al. Genetic evidence supports a major role for Akt1 in VSMCs during atherogenesis[J]. Circ Res, 2015, 116(11):1744-1752.
[4] Hu G, Niu F, Humburg BA, et al. Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis[J]. Oncotarget, 2018, 9(26):18648-18663.
[5] Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function[J]. Nat Rev Genet, 2016, 17(1):47-62.
[6] Mantella LE, Singh KK, Sandhu P, et al. Fingerprint of long non-coding RNA regulated by cyclic mechanical stretch in human aortic smooth muscle cells: implications for hypertension[J]. Mol Cell Biochem, 2017, 435(1/2):163-173.
[7] Frismantiene A, Philippova M, Erne P, et al. Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity[J]. Cell Signal, 2018, 52:48-64.
[8] Leung A, Stapleton K, Natarajan R. Functional long non-coding RNAs in vascular smooth muscle cells[J]. Curr Top Microbiol Immunol, 2016, 394:127-141.
[9] Wang J, Ma R, Ma W, et al. LncDisease: a sequence based bioinformatics tool for predicting lncRNA-disease associations[J]. Nucleic Acids Res, 2016, 44(9):e90.
[10] Shi L, Tian C, Sun L, et al. The lncRNA TUG1/miR-145-5p/FGF10 regulates proliferation and migration in VSMCs of hypertension[J]. Biochem Biophys Res Commun, 2018, 501(3):688-695.
[11] Jin L, Lin XJ, Yang L, et al. AK098656, a novel vascular smooth muscle cell-dominant long noncoding RNA, promotes hypertension[J]. Hypertension, 2018, 71(2):262-272.
[12] Fang G, Qi J, Huang L, et al. LncRNA MRAK048635_P1 is critical for vascular smooth muscle cell function and phenotypic switching in essential hypertension[J]. Biosci Rep, 2019, 39(3):BSR20182229.
[13] Jiang X, Ning Q. The mechanisms of lncRNA GAS5 in cardiovascular cells and its potential as novel therapeutic target[J]. J Drug Target, 2020, 28(10):1012-1017.
[14] Das S, Zhang E, Senapati P, et al. A novel angiotensin Ⅱ-induced long noncoding RNA giver regulates oxidative stress, inflammation, and proliferation in vascular smooth muscle cells[J]. Circ Res, 2018, 123(12):1298-1312.
[15] Liu L, Liu J, Huang Y. Protective effects of glucagon-like peptide 1 on endothelial function in hypertension[J]. J Cardiovasc Pharmacol, 2015, 65(5):399-405.
[16] Yang Y, Xi P, Xie Y, et al. Notoginsenoside R1 reduces blood pressure in spontaneously hypertensive rats through a long non-coding RNA AK094457[J]. Int J Clin Exp Pathol, 2015, 8(3):2700-2709.
[17] Xu J, Sun Y, Lu J. Knockdown of long noncoding RNA(lncRNA)AK094457 relieved angiotensin Ⅱ induced vascular endothelial cell injury[J]. Med Sci Monit, 2020, 26:e919854.
[18] Liu X, Li S, Yang Y, et al. The lncRNA ANRIL regulates endothelial dysfunction by targeting the let-7b/TGF-βR1 signalling pathway[J]. J Cell Physiol, 2021, 236(3):2058-2069.
[19] Lu Q, Meng Q, Qi M, et al. Shear-sensitive lncRNA AF131217.1 inhibits inflammation in HUVECs via regulation of KLF4[J]. Hypertension, 2019, 73(5):e25-e34.
[20] Bischoff FC, Werner A, John D, et al. Identification and functional characterization of hypoxia-induced endoplasmic reticulum stress regulating lncRNA(HypERlnc)in pericytes[J]. Circ Res, 2017, 121(4):368-375.
[21] Kontaraki JE, Marketou ME, Kochiadakis GE, et al. The long non-coding RNAs MHRT, FENDRR and Carmen, their expression levels in peripheral blood mononuclear cells in patients with essential hypertension and their relation to heart hypertrophy[J]. Clin Exp Pharmacol Physiol, 2018, 45(11):1213-1217.
[22] Yu J, Yang Y, Xu Z, et al. Long noncoding RNA Ahit protects against cardiac hypertrophy through SUZ12(suppressor of zeste 12 protein homolog)-mediated downregulation of MEF2A(myocyte enhancer factor 2a)[J]. Circ Heart Fail, 2020, 13(1):e006525.
[23] Dong B, Zhou B, Sun ZG, et al. LncRNA-FENDRR mediates VEGFA to promote the apoptosis of brain microvascular endothelial cells via regulating miR-126 in mice with hypertensive intracerebral hemorrhage[J]. Microcirculation, 2018, 25(8):e12499.
[24] Shen ZJ, Yc H, Wang YN, et al. LncRNA and mRNA expression profiles and functional networks of hyposalivation of the submandibular gland in hypertension[J]. Sci Rep, 2020, 10(1):13972.
[25] Wu H, Zhu S, Yuan R, et al. Transcriptome sequencing to detect the potential role of long noncoding RNAs in salt-sensitive hypertensive rats[J]. Biomed Res Int, 2019, 2019:2816959.
[26] Zhang L, Qi H, Liu Z, et al. Construction of a ceRNA coregulatory network and screening of hub biomarkers for salt-sensitive hypertension[J]. J Cell Mol Med, 2020, 24(13):7254-7265.
[27] Zhang X, Yang X, Lin Y, et al. Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension[J]. Int J Clin Exp Pathol, 2015, 8(6):6981-6987.
[28] Zhu J, Wang H, Chen H. Effects of estrogen on cardiac mRNA and lncRNA expression profiles in hypertensive mice[J]. J Cardiovasc Transl Res, 2021, 14(4):706-727.
[29] Withers SB, Saxton SN, Heagerty AM. Personalizing hypertension treatment?[J]. Hypertension, 2018, 71(6):1028-1029.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81900374); 吴阶平基金会项目(320.6750.2020-06-78)
通信作者:孔一慧,E-mail:kongyihui@126.com
更新日期/Last Update: 2021-12-01